ClassID:

170421

G01N2333/54 - page 2 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines Interleukins [IL]

Recent Application in this class:
#301
20100015132
2010-01-21

Uses of mammalian cytokines and agonists; related reagents

#302
20100003194
2010-01-07

Inhibitor screening method and atopic dermatitis like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same

#303
20090298081
2009-12-03

Methods of treatment utilizing binding proteins of the interleukin-21 receptor

#304
20090275135
2009-11-05

Method of treatment using an anti-IL-B50 antibody

#305
20090263377
2009-10-22

IL-32B-TARGETED DIAGNOSIS AND THERAPY

#306
20090215856
2009-08-27

Methods for monitoring IL-18

#307
20090214612
2009-08-27

EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS

#308
20090175943
2009-07-09

Transdiscal administration of specific inhibitors of pro-inflammatory cytokines

#309
20090162371
2009-06-25

Anti-IL-23 antibodies, compositions, methods and uses

#310
20090155364
2009-06-18

Transdiscal administration of anti-TNFα antibodies and growth differentiation factors

#311
20090130107
2009-05-21

INTERLEUKIN-22 POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME AND METHODS FOR THE TREATMENT OF PANCREATIC DISORDERS

#312
20090123456
2009-05-14

Treatment of inflammation using α7 receptor-binding cholinergic agonists

#313
20090093057
2009-04-09

Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

#314
20090068162
2009-03-12

Stationary Phase Antibody Arrays for Trace Protein Analysis

#315
20090053253
2009-02-26

Process for the measurement of the potency of glatiramer acetate

#316
20090004683
2009-01-01

Indicator Agent for Noninflammatory Stress Response and Use Thereof

#317
20090004199
2009-01-01

Antibodies that bind both IL-17A and IL-17F and methods of using the same

#318
20080305076
2008-12-11

Method of inducing memory B cell development and terminal differentiation

#319
20080279813
2008-11-13

Cd4+ Cd25+ T-cells activated to a specific antigen

#320
20080248025
2008-10-09

Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions

#321
20080241130
2008-10-02

METHODS AND COMPOSITIONS FOR MODULATING IL-17F/IL-17A BIOLOGICAL ACTIVITY

#322
20080227114
2008-09-18

COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION

#323
20080219995
2008-09-11

IL-32 monoclonal antibodies and uses thereof

#324
20080213817
2008-09-04

Enhancement of Th2-Dependent and Inflammatory Response

#325
20080213261
2008-09-04

Transdiscal administration of specific inhibitors of pro-inflammatory cytokines

#326
20080167264
2008-07-10

MATERIALS AND METHODS TO INHIBIT HODGKIN AND REED STERNBERG CELL GROWTH

#327
20080160021
2008-07-03

IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

#328
20080153172
2008-06-26

Method for the diagnosis of chronic stress and related disorders

#329
20080038758
2008-02-14

Diagnostic method for paratuberculosis

#330
20080038192
2008-02-14

Diagnostic Methods Of Multiple Organ Amyloidosis

#331
20070248981
2007-10-25

Predicting mortality and detecting severe disease

#332
20070237777
2007-10-11

Transdiscal administration of specific inhibitors of pro-inflammatory cytokines

#333
20070178097
2007-08-02

Interleukin-10 antibodies

#334
20070172457
2007-07-26

Interleukins-21 and 22

#335
20070160612
2007-07-12

Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

#336
20070154452
2007-07-05

Therapeutic agent for pancreas cancer

#337
20070092448
2007-04-26

Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same

#338
20070088003
2007-04-19

Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

#339
20070020735
2007-01-25

IL-17 receptor-like polypeptides and therapeutic uses thereof

#340
20070009526
2007-01-11

Anti-IL-23 antibodies, compositions, methods and uses

#341
20070003515
2007-01-04

Method of inducing memory B cell development and terminal differentiation

#342
20060177871
2006-08-10

Murine IL-18 crystal structure

#343
20060110386
2006-05-25

Mammalian cytokines; receptors; related reagents and methods

#344
20060068420
2006-03-30

Regulation of Th2 cell activity by modulation of NFATp and NFAT4 activity

#345
20060057123
2006-03-16

Method of inducing memory B cell development and terminal differentiation

#346
20060013802
2006-01-19

Techniques to treat neurological disorders by enhancing the presence of anti-inflammatory mediators

#347
20060009482
2006-01-12

Screening method for identifying compounds that selectively induce interferon alpha

#348
20050287606
2005-12-29

T1 receptor-like ligand I

#349
20050282232
2005-12-22

Compositions and methods for modulating c-Rel-dependent cytokine production

#350
20050277126
2005-12-15

Method and compositions for treating asthma

#351
20050209162
2005-09-22

Methods for monitoring IL-18

#352
20050208474
2005-09-22

Method and cell composition for screening compounds for anti-inflammatory activity

#353
20050180974
2005-08-18

Extracellular TNF inhibitors for treating CNS disorders

#354
20050175721
2005-08-11

Method of augmenting the immune-modulatory activity of standardized Echinacea preparations

#355
20050154192
2005-07-14

Anti-il13 receptor alpha1 neutralizing antibody

#356
20050148029
2005-07-07

Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes

#357
20050148023
2005-07-07

Screening for gestational disorders

#358
20050137218
2005-06-23

Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists

#359
20050101770
2005-05-12

Interleukin-10 antibodies

#360
20050096564
2005-05-05

Method of distributing skin care products

#361
20050095246
2005-05-05

Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators

#362
20050074822
2005-04-07

Method of detecting antigen-specific T lymphocytes

#363
20050074434
2005-04-07

Remedies for metabolic bone diseases

#364
20050048587
2005-03-03

Methods for identifying tolerance modulatory compounds and uses therefor

#365
20050048061
2005-03-03

Uses of mammalian cytokines and agonists; related reagents

#366
20050042678
2005-02-24

Method of using physiological markers to estimate cardiovascular risk

#367
20050014199
2005-01-20

Cytokine receptor

#368
15528172
2019-11-12

Peptides for use in treatment and diagnosis of type 1 diabetes